Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D06EMT
|
|||
Former ID |
DAP000754
|
|||
Drug Name |
Chlormerodrin
|
|||
Synonyms |
Chlormerodrina; Chloromeridin; Neogidrin; Chlormerodrin Hg 197; Chlormerodrin Hg 203; Chlormerodrin (197Hg); Chlormerodrin (203Hg); Chlormerodrin Hg 197 (TN); Chlormerodrin Hg 197 (USAN); Chlormerodrin Hg 197 [USAN:USP XX]; Chlormerodrin Hg 203 (USAN); Hg-203 chlormerodrin; Loro-}; Neohydrin-203; Chlormerodrin (197Hg) (INN); Neohydrin-203 (TN); Mercury, [3-[(aminocarbonyl)amino]-2-methoxypropyl]chloro; Urea, (2-methoxypropyl)-, mercury complex; [3-(carbamoylamino)-2-methoxypropyl](chloro)mercury; [3-(carbamoylamino)-2-methoxypropyl]-chloromercury; {[3-(Chloromercuri)-2-methoxypropyl]urea}; {[3-[(Aminocarbonyl)amino]-2-hydroxypropyl]chloromercury}; [3-(carbamoylamino)-2-methoxypropyl](chloro)(203hg)mercury; [3-(carbamoylamino)-2-methoxypropyl]-chloromercury-203; Chloro(2-methoxy-3-ureidopropyl)((203)Hg)mercury(II); Mercury, {[3-[(aminocarbonyl)amino]-2-methoxypropyl]chloro-}; [3-(carbamoylamino)-2-methoxypropyl](chloro)((203)Hg)mercury; Mercury, {[3-[(aminocarbonyl)amino]-2-methoxypropyl-C1,O3]ch; (3-(Chloromercuri)-2-methoxypropyl)urea; 3-Chloromercuri-2-methoxypropylurea; 3-ureido-2-methoxypropyl((203)Hg)mercury(II) chloride
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Diagnostic imaging [ICD-11: N.A.] | Approved | [1] | |
Therapeutic Class |
Diagnostic Agents
|
|||
Structure |
Download2D MOL
|
|||
Formula |
C5H11ClHgN2O2
|
|||
Canonical SMILES |
COC(CNC(=O)N)C[Hg]Cl
|
|||
InChI |
1S/C5H11N2O2.ClH.Hg/c1-4(9-2)3-7-5(6)8;;/h4H,1,3H2,2H3,(H3,6,7,8);1H;/q;;+1/p-1
|
|||
InChIKey |
BJFGVYCULWBXKF-UHFFFAOYSA-M
|
|||
CAS Number |
CAS 10375-56-1
|
|||
PubChem Compound ID | ||||
PubChem Substance ID | ||||
ChEBI ID |
CHEBI:59445
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Succinate-semialdehyde dehydrogenase (ALDH5A1) | Target Info | Modulator | [2] |
BioCyc | GABA shunt | |||
4-aminobutyrate degradation | ||||
KEGG Pathway | Alanine, aspartate and glutamate metabolism | |||
Butanoate metabolism | ||||
Metabolic pathways | ||||
Panther Pathway | Aminobutyrate degradation | |||
Gamma-aminobutyric acid synthesis | ||||
Pathwhiz Pathway | Glutamate Metabolism | |||
WikiPathways | GABA synthesis, release, reuptake and degradation |
References | Top | |||
---|---|---|---|---|
REF 1 | Drug information of Chlormerodrin, 2008. eduDrugs. | |||
REF 2 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.